News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Study opens up new way of treating rare cancer of arms and legs
The disease, called synovial sarcoma, showed unusual sensitivity to drugs that stop cells from repairing damage to their DNA.
Test reveals which breast cancer patients may benefit from targeted therapy
A new test could indicate which women with some breast cancer types are likely to benefit from targeted treatments, according to new research.
New, simple blood tests for prostate cancer
Conor McKeever introduces an exciting new technology, developed by researchers at The Institute of Cancer Research.
Top 10 scientific achievements of 2017
We've selected our top 10 discoveries of 2016/17 – chosen because they best represent the breadth of our research and our ambitions set out in our research strategy.
ICR researcher wins major prize at 2017 San Antonio Breast Cancer Symposium
An ICR researcher has been given a prestigious award at the San Antonio Breast Cancer Symposium, one of the world’s most important annual breast cancer research conferences.
ICR responds to NICE approval of new breakthrough drugs on the NHS for women with advanced breast cancer
The Institute of Cancer Research, London, welcomes the approval by NICE of a new type of treatment for women with previously untreated advanced breast cancer.
New treatment approach for rare type of ‘triple negative’ breast cancers identified
Leading scientists funded by Breast Cancer Now have identified a potential new treatment approach for some ‘triple negative’ breast cancers (TNBCs).
New three-in-one blood test opens door to precision medicine for prostate cancer
Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate cancer through use of precision drugs designed to target mutations in the BRCA genes.
Experimental drug could lead to potent combination in breast and other cancers
An experimental drug could be used in combination with chemotherapy as a treatment for breast and other cancers, new research shows.
Scientists create artificial ‘mini tumours’ to study cancer genes
A new technique to screen clumps of cancer cells in the lab which act like miniature tumours could help scientists discover potential new cancer drugs.
The ICR responds to decision by NICE not to recommend palbociclib
The Institute of Cancer Research, London, has expressed disappointment that the breast cancer drug palbociclib will not be made available to patients and is calling for urgent discussions to reduce the price of the drug.
Gene test could pinpoint patients sensitive to new type of cancer drug
Testing for a gene commonly mutated in ovarian cancers could pick out patients who will respond well to a promising new class of cancer drugs, a major new study reveals.
